Women can safely skip the unpleasant speculum-based exam for human papillomavirus screening and instead test for the virus ...

UroGen Pharma has opened another front in its attack on bladder cancer, paying IconOVir Bio $4 million in stock for an early-phase oncolytic virus that could work like a turbocharged Bacillus Calmette ...

They're all talking about HPV, or human papillomavirus. It's the most common sexually transmitted infection, but it's also ...

TVEC is a genetically modified herpes simplex virus that specifically destroys tumor cells and simultaneously activates the immune system. The aim of the study was to reduce the size of the tumor ...

Discover how HPV silently triggers throat cancer, why vaccination rates are dropping, and what medical experts say about ...

UroGen Pharma has broadened its oncology pipeline by acquiring IconOVir Bio’s assets related to the oncolytic virus ICVB-1042 ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...

Upon systemic infection from mosquito bites, Semliki Forest virus causes mild blood viremia ... AI Innovation Unlocks Non-Surgical Way to Detect Brain Cancer Spread Jan. 14, 2025 — Researchers ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center ...

Cervical cancer, caused by Human Papilloma Virus (HPV), is not hereditary, and HPV infection doesn't always lead to cancer.

Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying a specific gene improves the ability of immune cells to combat cancer for ...